If you take medication for high blood pressure, you may want to check your prescription bottle.
More than 13,500 bottles of chlorthalidone, a prescription drug used to treat high blood pressure, are being recalled nationwide. The recall involves one specific batch made by Inventia Healthcare Limited.
The company started the recall on Sept. 3, 2026. The U.S. Food and Drug Administration (FDA) classified it as a Class II recall on Sept. 17.
Why Is the Medication Being Recalled?
According to the FDA recall information, the chlorthalidone tablets failed what are known as “dissolution specifications.”
In simple terms, the tablets may not dissolve properly. A medication needs to dissolve correctly so the body can absorb its active ingredient. If that does not happen, a person may not receive the intended amount of medicine, potentially making the drug less effective.
The FDA has classified the recall as Class II. This category is used when a recalled product could cause temporary or medically reversible health problems, but the chance of serious health consequences is considered remote.
This is also not the first chlorthalidone recall involving Inventia Healthcare this year. A separate recall was initiated in June over the same issue with dissolution testing.
What Is Chlorthalidone?
Chlorthalidone is a type of medicine called a diuretic, commonly known as a “water pill.”
It helps the kidneys remove extra salt and water from the body. This can lower blood pressure and reduce fluid buildup.
Keeping high blood pressure under control is important because hypertension can damage the heart, blood vessels, brain, kidneys and eyes over time. It is also a major risk factor for heart disease and stroke.
How Common Is High Blood Pressure?
High blood pressure is extremely common in the United States.
According to the Centers for Disease Control and Prevention, approximately 119.9 million U.S. adults — nearly half of all adults — have high blood pressure. About 92.9 million adults with hypertension do not have their blood pressure under control.
High blood pressure often has no noticeable symptoms, which is one reason it can go undetected. The CDC defines hypertension as blood pressure that is consistently at or above 130/80 mm Hg.
The condition can become dangerous when it is not properly managed. In 2024, high blood pressure was listed as a primary or contributing cause in more than 680,000 deaths in the United States, according to the CDC.
Which Bottles Are Being Recalled?
The latest recall covers 13,567 bottles distributed nationwide. It does not include every chlorthalidone prescription.
People can check their medication for these details:
- Medication: Chlorthalidone Tablets, USP, 25 mg
- Bottle size: 100 tablets
- Manufacturer: Inventia Healthcare Limited
- NDC: 64980-599-01
- Batch number: RISA24002
- Expiration date: 04/2027
If you cannot find this information or are unsure whether your prescription is affected, contact your pharmacist.
Who Is Inventia Healthcare?
Inventia Healthcare Limited is a pharmaceutical company based in Mumbai, India. The company has been operating since 1985 and is involved in developing, manufacturing and selling pharmaceutical products, nutraceuticals and injectable medicines.
Inventia manufactured the chlorthalidone involved in the current U.S. recall.
What Should Patients Do?
People who believe they have medication from the recalled batch should contact their pharmacist or healthcare provider for instructions.
Most importantly, patients should not suddenly stop taking prescribed blood pressure medication without first speaking with a medical professional. Stopping or changing treatment could allow blood pressure to rise.
A pharmacist can also help confirm whether a bottle is part of the affected batch and explain what to do about a replacement.
Anyone experiencing concerning symptoms or who has questions about how the recall affects their treatment should contact their healthcare provider.





